NCT02826382View on ClinicalTrials.gov

Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 20, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Prostate CancerBone Metastases
Interventions
DRUG

[68Ga]P15-041

Imaging by Positron Emission Tomography after injection of \[68Ga\]P15-041

Trial Locations (1)

Unknown

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Five Eleven Pharma, Inc.

INDUSTRY

NCT02826382 - Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 | Biotech Hunter | Biotech Hunter